News

Collaboration in veterinary medicine

Leverkusen – A recently signed licensing agreement between the Animal Health Division of Bayer HealthCare AG and Juvaris BioTherapeutics, Inc. gives Bayer HealthCare complete access in the veterinary field to the mono-immunotherapy and vaccine technology being developed by Juvaris for human health care. The companies will work together on product development programs in the fields of immune stimulation and disease prevention in a variety of animal species.

In addition, Bayer Animal Health will financially support Juvaris’ research, product formulation, development and gmp manufacturing activities. The license agreement is worldwide in scope. A joint steering committee made up of executives from both companies will ensure compliance with the agreement terms as the work proceeds.